Latest filing published 14 Sept 2022 for Mydecine Innovations Group Inc..
No signal scores available.
Damon Michaels appears in our data through filings on Mydecine Innovations Group Inc. shares, published by SEDI. In total, 6 filings cover trades dated from 11 May 2020 to 13 April 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 14 September 2022, reports a transaction in Mydecine Innovations Group Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations